Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.03
-0.76-15.87%
Last update: Dec 16, 10:57 AM
Comments
Loading...
Cellectis Analyst Ratings and Price Targets | NASDAQ:CLLS | Benzinga
Cellectis SA has a consensus price target of $10 based on the ratings of 4 analysts. The high is $16 issued by Citigroup on April 5, 2023. The low is $6 issued by JMP Securities on May 31, 2024. The 3 most-recent analyst ratings were released by Barclays on October 17, 2025, May 13, 2025, and November 5, 2024, respectively. With an average price target of $5.67 between Barclays, there's an implied 40.61% upside for Cellectis SA from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Oppenheimer
JMP Securities
Citigroup
1calculated from analyst ratings
Analyst Ratings for Cellectis
FAQ
What is the target price for Cellectis (CLLS) stock?
The latest price target for Cellectis (NASDAQ:CLLS) was reported by Barclays on October 17, 2025. The analyst firm set a price target for $8.00 expecting CLLS to rise to within 12 months (a possible 98.51% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cellectis (CLLS)?
The latest analyst rating for Cellectis (NASDAQ:CLLS) was provided by Barclays, and Cellectis maintained their overweight rating.
When was the last upgrade for Cellectis (CLLS)?
There is no last upgrade for Cellectis
When was the last downgrade for Cellectis (CLLS)?
There is no last downgrade for Cellectis.
When is the next analyst rating going to be posted or updated for Cellectis (CLLS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cellectis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cellectis was filed on October 17, 2025 so you should expect the next rating to be made available sometime around October 17, 2026.
Is the Analyst Rating Cellectis (CLLS) correct?
While ratings are subjective and will change, the latest Cellectis (CLLS) rating was a maintained with a price target of $4.00 to $8.00. The current price Cellectis (CLLS) is trading at is $4.03, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
